Martin Dahl
Corporate Officer/Principal presso ANAPTYSBIO, INC.
Profilo
Martin Dahl is currently working as a Senior Vice President-Research at AnaptysBio, Inc. Previously, he worked as the Global Head-Immunology Network at Takeda Pharmaceuticals U.S.A., Inc. Dr. Dahl completed his undergraduate degree at the University of California, Irvine and holds a doctorate degree from the University of Tokyo.
Posizioni attive di Martin Dahl
| Società | Posizione | Inizio |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01/01/2018 |
Precedenti posizioni note di Martin Dahl
| Società | Posizione | Fine |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formazione di Martin Dahl
| University of California, Irvine | Undergraduate Degree |
| University of Tokyo | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Borsa valori
- Insiders
- Martin Dahl
